In this study, EGFR mutation detection was possible if 1.5% of carcinoma cells were included, but detection was also possible by cytology if the cancer cell content was 0.1% since background cells such as inflammatory cells and debris could be removed from the specimen. Here, EGFR is linked to carcinoma.